Arcellx (ACLX) Other Gross PP&E Adjustments (2021 - 2025)
Arcellx (ACLX) recorded quarterly Other Gross PP&E Adjustments of $23.4 million in Q4 2025, up 200.64% quarter-over-quarter from -$23.2 million in Q3 2025, and down 2.58% on a YoY basis from $24.0 million in Q4 2024.
Arcellx (ACLX) Other Gross PP&E Adjustments (2021 - 2025) Analysis & Trends
Arcellx's Other Gross PP&E Adjustments history runs 5 years deep, the most recent figure standing at $23.4 million for Q4 2025.
- In Q4 2025, Other Gross PP&E Adjustments fell 2.58% year-over-year to $23.4 million; the TTM figure through Dec 2025 stood at $23.4 million (down 2.58% YoY), while the FY2025 annual figure was $23.4 million, down 2.58% from the prior year.
- Other Gross PP&E Adjustments was $23.4 million for Q4 2025 at Arcellx, up from -$23.2 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $24.0 million in Q4 2024 to a low of -$29.6 million in Q1 2023.
- Historically, Other Gross PP&E Adjustments has averaged -$13.8 million across 5 years, with a median of -$23.6 million in 2025.
- Biggest YoY gain for Other Gross PP&E Adjustments was 178.4% in 2023; the steepest drop was 826.41% in 2023.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $12.5 million in 2021, then slumped by 266.42% to -$20.8 million in 2022, then surged by 178.4% to $16.3 million in 2023, then surged by 47.37% to $24.0 million in 2024, then fell by 2.58% to $23.4 million in 2025.
- The last three Other Gross PP&E Adjustments figures came in at $23.4 million (Q4 2025), -$23.2 million (Q3 2025), and -$23.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | -60,691.22 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -83,048.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -285.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -892,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -1.69 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 23.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.37 Mn |
| Dec 31, 2025 | 23.37 Mn |
| Sep 30, 2025 | -23.23 Mn |
| Sep 30, 2025 | -23.23 Mn |
| Jun 30, 2025 | -23.42 Mn |
| Jun 30, 2025 | -23.42 Mn |
| Mar 31, 2025 | -23.60 Mn |
| Mar 31, 2025 | -23.60 Mn |
| Dec 31, 2024 | 23.99 Mn |
| Dec 31, 2024 | 23.99 Mn |
| Sep 30, 2024 | -23.93 Mn |
| Sep 30, 2024 | -23.93 Mn |
| Jun 30, 2024 | -24.07 Mn |
| Jun 30, 2024 | -24.07 Mn |
| Mar 31, 2024 | -24.20 Mn |
| Mar 31, 2024 | -24.20 Mn |
| Dec 31, 2023 | 16.28 Mn |
| Dec 31, 2023 | 16.28 Mn |
| Sep 30, 2023 | -29.14 Mn |
| Sep 30, 2023 | -29.14 Mn |